Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Themis Medicare Limited ( (IN:THEMISMED) ) has provided an update.
Themis Medicare Limited announced the appointment of Ms. Neha Thakore as an Independent Director and Mr. Viraj Save as Executive President of Sales & Marketing, effective August 1, 2025. These appointments are part of the company’s strategic efforts to strengthen its leadership team and enhance its market position. Additionally, the company approved its unaudited financial results for the quarter ending June 30, 2025, and set a record date for determining dividend entitlements, indicating a focus on financial transparency and shareholder value.
More about Themis Medicare Limited
Themis Medicare Limited operates in the pharmaceutical industry, specializing in Active Pharmaceutical Ingredients (API) and other pharmaceutical products. The company focuses on strategic growth and sustainability, with a strong emphasis on corporate governance and industry development.
Average Trading Volume: 16,949
Technical Sentiment Signal: Sell
Current Market Cap: 9.89B INR
Learn more about THEMISMED stock on TipRanks’ Stock Analysis page.